Signature Resources Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4K Buy
17
+1
+6% +$1.02K 0.01% 237
2026
Q1
$14.7K Buy
16
+1
+7% +$1.01K 0.01% 247
2025
Q4
$16.1K Buy
15
+3
+25% +$2.87K 0.01% 232
2025
Q3
$9.16K Hold
12
0.01% 288
2025
Q2
$9.35K Buy
+12
New +$9.32K 0.01% 279
2024
Q3
Sell
-10
Closed -$9.05K 406
2024
Q2
$9.05K Hold
10
0.01% 223
2024
Q1
$5.83K Hold
10
0.01% 230
2023
Q4
$5.83K Buy
+10
New +$5.84K 0.01% 232

Other funds holding LLY

Signature Resources Capital Management's LLY Position: Q2 2026 in Review

Signature Resources Capital Management increased its Eli Lilly (LLY) stake by 6.3% in Q2 2026, buying an estimated $1.02K and bringing the position to 17 shares worth $20.4K. The position accounts for 0.01% of the portfolio, ranked #237.

Signature Resources Capital Management first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signature Resources Capital Management held 17 shares of Eli Lilly worth $20.4K as of Q2 2026.
  • Signature Resources Capital Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #237 holding.
  • Signature Resources Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.